Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
3.970
-0.070 (-1.73%)
At close: Jun 9, 2026, 4:00 PM EDT
4.040
+0.070 (1.76%)
After-hours: Jun 9, 2026, 4:15 PM EDT
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $223.13 million as of June 9, 2026. Its market cap has increased by 82.44% in one year.
Market Cap
223.13M
Enterprise Value
48.76M
1-Year Change
82.44%
Ranking
Category
Stock Price
$3.97
Market Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $223.13M, an increase of 28.86%. That is a compound annual growth rate of 4.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 227.07M | -20.50% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fulcrum Therapeutics | 245.88M |
| Elicio Therapeutics | 243.93M |
| Anavex Life Sciences | 238.17M |
| SAB Biotherapeutics | 237.53M |
| Orchestra BioMed Holdings | 233.53M |
| Codexis | 232.70M |
| Minerva Neurosciences | 231.08M |
| Fate Therapeutics | 230.79M |